Literature DB >> 22941050

Attenuated effects of experimenter-administered heroin in adolescent vs. adult male rats: physical withdrawal and locomotor sensitization.

James M Doherty1, Kyle J Frantz.   

Abstract

OBJECTIVES: Early onset of heroin use during adolescence might increase chances of later drug addiction. Prior work from our laboratory suggests, however, that adolescent male rats are actually less sensitive than adults to some enduring effects of heroin self-administration. In the present study, we tested two likely correlates of sensitivity to behavioral reinforcement in rats: physical withdrawal and locomotor sensitization.
METHODS: Adolescent (35 days old at start) and adult (79 days old) male Sprague-Dawley rats were administered escalating doses of heroin, increasing from 1.0 to 8.0 mg/kg (i.p.) every 12 h, across 13 days. Somatic signs of spontaneous withdrawal were scored 12 and 24 h after the last injection, and then every 24 h for 5 days; locomotion was recorded concurrently. Challenge injections of heroin (1 mg/kg i.p.) were given at four points: as the first of the escalating doses (day 1), at days 7 and 13 during the escalating regimen, and after 12 days of forced abstinence. Body mass and food intake were measured throughout experimentation.
RESULTS: A heroin withdrawal syndrome was not observed among adolescents as it was among adults, including somatic signs as well as reduced locomotion, body mass, and food intake. On the other hand, heroin-induced locomotor sensitization did not differ across ages.
CONCLUSION: Reduced withdrawal is consistent with the attenuated reinforcing effects of heroin among adolescent male rats that we reported previously. Thus, it is possible that adolescent rats could reveal important neuroprotective factors for use in treatment of heroin dependence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22941050      PMCID: PMC3547165          DOI: 10.1007/s00213-012-2847-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  58 in total

Review 1.  Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure.

Authors:  David H Epstein; Kenzie L Preston; Jane Stewart; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2006-09-22       Impact factor: 4.530

2.  Early-onset drug use and risk of later drug problems.

Authors:  J C Anthony; K R Petronis
Journal:  Drug Alcohol Depend       Date:  1995-11       Impact factor: 4.492

Review 3.  Pharmacologic treatment of heroin-dependent patients.

Authors:  P G O'Connor; D A Fiellin
Journal:  Ann Intern Med       Date:  2000-07-04       Impact factor: 25.391

Review 4.  Sensitization processes in drug addiction.

Authors:  Louk J M J Vanderschuren; R Christopher Pierce
Journal:  Curr Top Behav Neurosci       Date:  2010

5.  Effect of repeated administrations of heroin, naltrexone, methadone, and alcohol on morphine glucuronidation in the rat.

Authors:  Letizia Antonilli; Emma Petecchia; Daniele Caprioli; Aldo Badiani; Paolo Nencini
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

Review 6.  Neural substrates of opiate withdrawal.

Authors:  G F Koob; R Maldonado; L Stinus
Journal:  Trends Neurosci       Date:  1992-05       Impact factor: 13.837

7.  Modulatory effect of environmental context and drug history on heroin-induced psychomotor activity and fos protein expression in the rat brain.

Authors:  Giovanna Paolone; David Conversi; Daniele Caprioli; Paola Del Bianco; Paolo Nencini; Simona Cabib; Aldo Badiani
Journal:  Neuropsychopharmacology       Date:  2007-03-28       Impact factor: 7.853

8.  Involvement of arginine vasopressin and V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin.

Authors:  Yan Zhou; Francesco Leri; Erin Cummins; Marisa Hoeschele; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2007-04-18       Impact factor: 7.853

9.  Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone.

Authors:  Ebony M Glover; Michael Davis
Journal:  Psychopharmacology (Berl)       Date:  2008-03-07       Impact factor: 4.530

10.  Developmental epidemiology of drug use and abuse in adolescence and young adulthood: Evidence of generalized risk.

Authors:  R H C Palmer; S E Young; C J Hopfer; R P Corley; M C Stallings; T J Crowley; J K Hewitt
Journal:  Drug Alcohol Depend       Date:  2009-02-27       Impact factor: 4.492

View more
  6 in total

1.  Morphine-induced conditioned place preference and effects of morphine pre-exposure in adolescent and adult male C57BL/6J mice.

Authors:  Wouter Koek
Journal:  Psychopharmacology (Berl)       Date:  2014-07-29       Impact factor: 4.530

Review 2.  Emergence of sex differences in the development of substance use and abuse during adolescence.

Authors:  Cynthia Kuhn
Journal:  Pharmacol Ther       Date:  2015-06-03       Impact factor: 12.310

3.  A role for the prefrontal cortex in heroin-seeking after forced abstinence by adult male rats but not adolescents.

Authors:  James M Doherty; Bradley M Cooke; Kyle J Frantz
Journal:  Neuropsychopharmacology       Date:  2012-10-17       Impact factor: 7.853

4.  Effects of repeated exposure to morphine in adolescent and adult male C57BL/6J mice: age-dependent differences in locomotor stimulation, sensitization, and body weight loss.

Authors:  Wouter Koek
Journal:  Psychopharmacology (Berl)       Date:  2013-10-06       Impact factor: 4.530

5.  Paradoxical changes in brain reward status during oxycodone self-administration in a novel test of the negative reinforcement hypothesis.

Authors:  Jacques D Nguyen; Yanabel Grant; Michael A Taffe
Journal:  Br J Pharmacol       Date:  2021-06-08       Impact factor: 9.473

6.  Aloe vera Aqueous Extract Effect on Morphine Withdrawal Syndrome in Morphine-Dependent Female Rats.

Authors:  Mohammad Reza Shahraki; Hamideh Mirshekari; Azame Sabri
Journal:  Int J High Risk Behav Addict       Date:  2014-07-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.